Search research articles
Contact Us
Filters
Showing results (371-380 of 376) with videos related to
Page
of 38
Sort By:
You have reached the last page of results.
This site can display upto 376 results.
European Journal of Cancer (Oxford, England : 1990)
|
March 24, 2018
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
Daniela Cardinale, Fabio Ciceri, Roberto Latini, et al.
ESC Heart Failure
|
May 3, 2020
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial
Jennifer M T A Meessen, Daniela Cardinale, Fabio Ciceri, et al.
Clinical Therapeutics
|
February 25, 2024
Effectiveness, Tolerability, and Safety of Different Amphotericin B Formulations in Invasive Fungal Infections: A Multicenter, Retrospective, Observational Study
Francelise Bridi Cavassin, Marcello Mihailenko Chaves Magri, Jose Ernesto Vidal, et al.
The Journal of Antimicrobial Chemotherapy
|
July 29, 2024
A multicentre study of amphotericin B treatment for histoplasmosis: assessing mortality rates and adverse events
William Kazunori Sekiguchi, Vítor Falcão de Oliveira, Francelise Bridi Cavassin, et al.
Plos Neglected Tropical Diseases
|
January 5, 2023
The "Histoplasmosis Porto Alegre manifesto"-Addressing disseminated histoplasmosis in AIDS
Alessandro C Pasqualotto, Flavio Queiroz-Telles, Alberto Chebabo, et al.
Emerging Infectious Diseases
|
March 21, 2026
New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group
Alessandro C Pasqualotto, David W Denning, Thuy Le, et al.
Page
of 38
Search research articles
Search
Showing results (371-380 of 376) with videos related to
Sort By:
Page
of 38
You have reached the last page of results.
This site can display upto 376 results.
European Journal of Cancer (Oxford, England : 1990)
|
March 24, 2018
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
Daniela Cardinale, Fabio Ciceri, Roberto Latini, et al.
ESC Heart Failure
|
May 3, 2020
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial
Jennifer M T A Meessen, Daniela Cardinale, Fabio Ciceri, et al.
Clinical Therapeutics
|
February 25, 2024
Effectiveness, Tolerability, and Safety of Different Amphotericin B Formulations in Invasive Fungal Infections: A Multicenter, Retrospective, Observational Study
Francelise Bridi Cavassin, Marcello Mihailenko Chaves Magri, Jose Ernesto Vidal, et al.
The Journal of Antimicrobial Chemotherapy
|
July 29, 2024
A multicentre study of amphotericin B treatment for histoplasmosis: assessing mortality rates and adverse events
William Kazunori Sekiguchi, Vítor Falcão de Oliveira, Francelise Bridi Cavassin, et al.
Plos Neglected Tropical Diseases
|
January 5, 2023
The "Histoplasmosis Porto Alegre manifesto"-Addressing disseminated histoplasmosis in AIDS
Alessandro C Pasqualotto, Flavio Queiroz-Telles, Alberto Chebabo, et al.
Emerging Infectious Diseases
|
March 21, 2026
New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group
Alessandro C Pasqualotto, David W Denning, Thuy Le, et al.
Page
of 38